10-69498334-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012339.5(TSPAN15):c.508G>A(p.Asp170Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000235 in 1,613,752 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012339.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TSPAN15 | NM_012339.5 | c.508G>A | p.Asp170Asn | missense_variant | 5/8 | ENST00000373290.7 | NP_036471.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TSPAN15 | ENST00000373290.7 | c.508G>A | p.Asp170Asn | missense_variant | 5/8 | 1 | NM_012339.5 | ENSP00000362387.2 |
Frequencies
GnomAD3 genomes AF: 0.0000395 AC: 6AN: 152010Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251142Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135808
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461742Hom.: 0 Cov.: 30 AF XY: 0.0000206 AC XY: 15AN XY: 727182
GnomAD4 genome AF: 0.0000395 AC: 6AN: 152010Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74228
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 03, 2022 | The c.508G>A (p.D170N) alteration is located in exon 5 (coding exon 5) of the TSPAN15 gene. This alteration results from a G to A substitution at nucleotide position 508, causing the aspartic acid (D) at amino acid position 170 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at